NCT00540228 - Study to Evaluate an Influenza Vaccine Candidate | Biotech Hunter

Enrollment

1,006

Participants

Timeline

Start Date

October 5, 2007

Primary Completion Date

May 8, 2008

Study Completion Date

May 8, 2008

Conditions

Influenza

Interventions

BIOLOGICAL

Influenza Vaccine GSK1247446A - 4 different formulations

Single dose, Intramuscular injection

BIOLOGICAL

Fluarix™

Single dose, Intramuscular injection

Trial Locations (15)

14052

GSK Investigational Site, Caen

17140

GSK Investigational Site, Lagord

28035

GSK Investigational Site, Madrid

28040

GSK Investigational Site, Madrid

31300

GSK Investigational Site, Toulouse

59019

GSK Investigational Site, Lille

72074

GSK Investigational Site, Tübingen

75679

GSK Investigational Site, Paris

75877

GSK Investigational Site, Paris

97070

GSK Investigational Site, Würzburg

01307

GSK Investigational Site, Dresden

09599

GSK Investigational Site, Freiberg

01762

GSK Investigational Site, Schmiedeberg

08035

GSK Investigational Site, Barcelona

08036

GSK Investigational Site, Barcelona